Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katsutoshi Seto

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Thoracic Cancer|May 7, 2020
Targeted RNA sequencing with touch imprint cytology samples for non-small cell lung cancer patientsKatsutoshi Seto, Katsuhiro Masago, Shiro Fujita, et al.
World Journal of Surgery|January 14, 2022
Postoperative Delirium in Lung Cancer Anatomical Resection-Analysis of Risk Factors and PrognosisHironori Ishibashi, Ryo Wakejima, Ayaka Asakawa, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 4, 2024
Impact of intrapulmonary tumour location of non-small-cell lung cancer on surgical outcomes for segmentectomyTakuya Matsui, Yusuke Takahashi, Takeo Nakada, et al.
Interdisciplinary Cardiovascular and Thoracic Surgery|September 25, 2025
Detection of Sleep-Disordered Breathing Using Carbon Nanotube Sensors Predicts Complications After Lung SurgeryYasuhiro Nakashima, Masashi Kobayashi, Ayaka Asakawa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 9, 2020
Novel Resistance Mechanisms Including L1196Q, P1094H, and R1248_D1249 Insertion in Three Patients With NSCLC After ALK Tyrosine Kinase Inhibitor TreatmentHiromi Furuta, Mitsugu Araki, Katsuhiro Masago, et al.
Pathology International|January 24, 2020
Negative reactions of BRAF mutation-specific immunohistochemistry to non-V600E mutations of BRAFKatsutoshi Seto, Masataka Haneda, Katsuhiro Masago, et al.
Cancer Genetics|May 22, 2022
Sensitivity to dabrafenib and trametinib treatments in patients with non-small-cell cancer harboring BRAF compound mutations: A pooled analysis of BRAF p.V600E-positive advanced non-small-cell lung cancerKatsutoshi Seto, Junichi Shimizu, Katsuhiro Masago, et al.
Cancer Medicine|September 15, 2023
The possibility of mutations of RAS signaling genes and/or TP53 in combination as a negative prognostic impact on pathological stage I non-small cell lung cancerTakayuki Honda, Katsutoshi Seto, Satoshi Endo, et al.
Thoracic Cancer|December 17, 2025
Salvage Surgery Following Systemic Therapy in Initially Unresectable Non-Small Cell Lung CancerKatsutoshi Seto, Yoshitsugu Horio, Katsuhiro Masago, et al.
JTCVS Open|September 19, 2024
Immunohistochemistry of p53 surrogates <i>TP53</i> mutation as an accurate predictor for early-relapse of surgically resected stage I-III lung adenocarcinomaYasuyuki Kurihara, Takayuki Honda, Akira Takemoto, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Thoracic Cancer|May 7, 2020
Targeted RNA sequencing with touch imprint cytology samples for non-small cell lung cancer patientsKatsutoshi Seto, Katsuhiro Masago, Shiro Fujita, et al.
World Journal of Surgery|January 14, 2022
Postoperative Delirium in Lung Cancer Anatomical Resection-Analysis of Risk Factors and PrognosisHironori Ishibashi, Ryo Wakejima, Ayaka Asakawa, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 4, 2024
Impact of intrapulmonary tumour location of non-small-cell lung cancer on surgical outcomes for segmentectomyTakuya Matsui, Yusuke Takahashi, Takeo Nakada, et al.
Interdisciplinary Cardiovascular and Thoracic Surgery|September 25, 2025
Detection of Sleep-Disordered Breathing Using Carbon Nanotube Sensors Predicts Complications After Lung SurgeryYasuhiro Nakashima, Masashi Kobayashi, Ayaka Asakawa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 9, 2020
Novel Resistance Mechanisms Including L1196Q, P1094H, and R1248_D1249 Insertion in Three Patients With NSCLC After ALK Tyrosine Kinase Inhibitor TreatmentHiromi Furuta, Mitsugu Araki, Katsuhiro Masago, et al.
Pathology International|January 24, 2020
Negative reactions of BRAF mutation-specific immunohistochemistry to non-V600E mutations of BRAFKatsutoshi Seto, Masataka Haneda, Katsuhiro Masago, et al.
Cancer Genetics|May 22, 2022
Sensitivity to dabrafenib and trametinib treatments in patients with non-small-cell cancer harboring BRAF compound mutations: A pooled analysis of BRAF p.V600E-positive advanced non-small-cell lung cancerKatsutoshi Seto, Junichi Shimizu, Katsuhiro Masago, et al.
Cancer Medicine|September 15, 2023
The possibility of mutations of RAS signaling genes and/or TP53 in combination as a negative prognostic impact on pathological stage I non-small cell lung cancerTakayuki Honda, Katsutoshi Seto, Satoshi Endo, et al.
Thoracic Cancer|December 17, 2025
Salvage Surgery Following Systemic Therapy in Initially Unresectable Non-Small Cell Lung CancerKatsutoshi Seto, Yoshitsugu Horio, Katsuhiro Masago, et al.
JTCVS Open|September 19, 2024
Immunohistochemistry of p53 surrogates <i>TP53</i> mutation as an accurate predictor for early-relapse of surgically resected stage I-III lung adenocarcinomaYasuyuki Kurihara, Takayuki Honda, Akira Takemoto, et al.
Pageof 4